Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.

Sanjay S. Subramanian
CFO & Head of Corporate Development
Bruce D. Forrest
Acting CMO
Michael Shine
SVP, Commercial
Vijay Tammara
SVP, Regulatory & Quality
J.P. Gabriel
SVP, Manufacturing & Supply Chain
Arun Upadhyay
VP, Research & Development
Zara Gaudioso
Head of Human Resources

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.